PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans

Purpose The α 7 nicotinic acetylcholine receptor (nAChR) is implicated in many neuropsychiatric disorders, making it an important target for positron emission tomography (PET) imaging. The first aim of this work was to compare two α 7 nAChRs PET radioligands, [ 18 F]ASEM (3-(1,4-diazabicyclo[3.2.2]n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of nuclear medicine and molecular imaging 2017-06, Vol.44 (6), p.1042-1050
Hauptverfasser: Hillmer, Ansel T., Li, Songye, Zheng, Ming-Qiang, Scheunemann, Matthias, Lin, Shu-fei, Nabulsi, Nabeel, Holden, Daniel, Pracitto, Richard, Labaree, David, Ropchan, Jim, Teodoro, Rodrigo, Deuther-Conrad, Winnie, Esterlis, Irina, Cosgrove, Kelly P., Brust, Peter, Carson, Richard E., Huang, Yiyun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1050
container_issue 6
container_start_page 1042
container_title European journal of nuclear medicine and molecular imaging
container_volume 44
creator Hillmer, Ansel T.
Li, Songye
Zheng, Ming-Qiang
Scheunemann, Matthias
Lin, Shu-fei
Nabulsi, Nabeel
Holden, Daniel
Pracitto, Richard
Labaree, David
Ropchan, Jim
Teodoro, Rodrigo
Deuther-Conrad, Winnie
Esterlis, Irina
Cosgrove, Kelly P.
Brust, Peter
Carson, Richard E.
Huang, Yiyun
description Purpose The α 7 nicotinic acetylcholine receptor (nAChR) is implicated in many neuropsychiatric disorders, making it an important target for positron emission tomography (PET) imaging. The first aim of this work was to compare two α 7 nAChRs PET radioligands, [ 18 F]ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-([ 18 F]fluorodibenzo[ b,d ]thiophene 5,5-dioxide) and [ 18 F]DBT-10 (7-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-2-([ 18 F]fluorodibenzo[ b,d ]thiophene 5,5-dioxide), in nonhuman primates. The second aim was to assess further the quantification and test-retest variability of [ 18 F]ASEM in humans. Methods PET scans with high specific activity [ 18 F]ASEM or [ 18 F]DBT-10 were acquired in three rhesus monkeys (one male, two female), and the kinetic properties of these radiotracers were compared. Additional [ 18 F]ASEM PET scans with blocking doses of nicotine, varenicline, and cold ASEM were acquired separately in two animals. Next, six human subjects (five male, one female) were imaged with [ 18 F]ASEM PET for 180 min, and arterial sampling was used to measure the parent input function. Different modeling approaches were compared to identify the optimal analysis method and scan duration for quantification of [ 18 F]ASEM distribution volume ( V T ). In addition, retest scans were acquired in four subjects (three male, one female), and the test-retest variability of V T was assessed. Results In the rhesus monkey brain [ 18 F]ASEM and [ 18 F]DBT-10 exhibited highly similar kinetic profiles. Dose-dependent blockade of [ 18 F]ASEM binding was observed, while administration of either nicotine or varenicline did not change [ 18 F]ASEM V T . [ 18 F]ASEM was selected for further validation because it has been used in humans. Accurate quantification of [ 18 F]ASEM V T in humans was achieved using multilinear analysis with at least 90 min of data acquisition, resulting in V T values ranging from 19.6 ± 2.5 mL/cm 3 in cerebellum to 25.9 ± 2.9 mL/cm 3 in thalamus. Test-retest variability of V T was 11.7 ± 9.8%. Conclusions These results confirm [ 18 F]ASEM as a suitable radiotracer for the imaging and quantification of α 7 nAChRs in humans.
doi_str_mv 10.1007/s00259-017-3621-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1861868105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1861868105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3458-6c88aa74578141a330289f687f3693131821fef23fc6c56ed2eeadc20c8649403</originalsourceid><addsrcrecordid>eNp9kc1KxDAUhYsoOI4-gLssXVjNbdo0defP-AOKguNKJITMzUylk4xJK8wrufNFfCYzUxHcCOEmF853wuEkyT7QI6C0PA6UZkWVUihTxjNIxUYyAA5VWlJRbf6-S7qd7ITwSimITFSD5ONhNCb1XE1rOyXOkK_Pkthau7aOkyiN7bLRM9fUFolHjYvW-XBCFNFuvlBetfU7ktB2k-WKfgZx-XL6OLojyk767eJsnAIltSXW2Vk3V5YsfPywxXC4VpnOtzP0BN9V00U_Z_86RXKNhd1ky6gm4N7PPUyeLkfj8-v09v7q5vz0NtUsL0TKtRBKlXlRCshBMUZjUMNFaRivGLAYHAyajBnNdcFxkiGqic6oFjyvcsqGyUHvu_DurcPQynkdNDaNsui6IEHweATQIkqhl2rvQvBo5DqbX0qgctWL7HuRsRe56kWKyGQ9E6LWTtHLV9d5GxP9A30DxRmP3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1861868105</pqid></control><display><type>article</type><title>PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans</title><source>SpringerLink Journals - AutoHoldings</source><creator>Hillmer, Ansel T. ; Li, Songye ; Zheng, Ming-Qiang ; Scheunemann, Matthias ; Lin, Shu-fei ; Nabulsi, Nabeel ; Holden, Daniel ; Pracitto, Richard ; Labaree, David ; Ropchan, Jim ; Teodoro, Rodrigo ; Deuther-Conrad, Winnie ; Esterlis, Irina ; Cosgrove, Kelly P. ; Brust, Peter ; Carson, Richard E. ; Huang, Yiyun</creator><creatorcontrib>Hillmer, Ansel T. ; Li, Songye ; Zheng, Ming-Qiang ; Scheunemann, Matthias ; Lin, Shu-fei ; Nabulsi, Nabeel ; Holden, Daniel ; Pracitto, Richard ; Labaree, David ; Ropchan, Jim ; Teodoro, Rodrigo ; Deuther-Conrad, Winnie ; Esterlis, Irina ; Cosgrove, Kelly P. ; Brust, Peter ; Carson, Richard E. ; Huang, Yiyun</creatorcontrib><description>Purpose The α 7 nicotinic acetylcholine receptor (nAChR) is implicated in many neuropsychiatric disorders, making it an important target for positron emission tomography (PET) imaging. The first aim of this work was to compare two α 7 nAChRs PET radioligands, [ 18 F]ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-([ 18 F]fluorodibenzo[ b,d ]thiophene 5,5-dioxide) and [ 18 F]DBT-10 (7-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-2-([ 18 F]fluorodibenzo[ b,d ]thiophene 5,5-dioxide), in nonhuman primates. The second aim was to assess further the quantification and test-retest variability of [ 18 F]ASEM in humans. Methods PET scans with high specific activity [ 18 F]ASEM or [ 18 F]DBT-10 were acquired in three rhesus monkeys (one male, two female), and the kinetic properties of these radiotracers were compared. Additional [ 18 F]ASEM PET scans with blocking doses of nicotine, varenicline, and cold ASEM were acquired separately in two animals. Next, six human subjects (five male, one female) were imaged with [ 18 F]ASEM PET for 180 min, and arterial sampling was used to measure the parent input function. Different modeling approaches were compared to identify the optimal analysis method and scan duration for quantification of [ 18 F]ASEM distribution volume ( V T ). In addition, retest scans were acquired in four subjects (three male, one female), and the test-retest variability of V T was assessed. Results In the rhesus monkey brain [ 18 F]ASEM and [ 18 F]DBT-10 exhibited highly similar kinetic profiles. Dose-dependent blockade of [ 18 F]ASEM binding was observed, while administration of either nicotine or varenicline did not change [ 18 F]ASEM V T . [ 18 F]ASEM was selected for further validation because it has been used in humans. Accurate quantification of [ 18 F]ASEM V T in humans was achieved using multilinear analysis with at least 90 min of data acquisition, resulting in V T values ranging from 19.6 ± 2.5 mL/cm 3 in cerebellum to 25.9 ± 2.9 mL/cm 3 in thalamus. Test-retest variability of V T was 11.7 ± 9.8%. Conclusions These results confirm [ 18 F]ASEM as a suitable radiotracer for the imaging and quantification of α 7 nAChRs in humans.</description><identifier>ISSN: 1619-7070</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/s00259-017-3621-8</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Cardiology ; Imaging ; Medicine ; Medicine &amp; Public Health ; Nuclear Medicine ; Oncology ; Original Article ; Orthopedics ; Radiology</subject><ispartof>European journal of nuclear medicine and molecular imaging, 2017-06, Vol.44 (6), p.1042-1050</ispartof><rights>Springer-Verlag Berlin Heidelberg 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3458-6c88aa74578141a330289f687f3693131821fef23fc6c56ed2eeadc20c8649403</citedby><cites>FETCH-LOGICAL-c3458-6c88aa74578141a330289f687f3693131821fef23fc6c56ed2eeadc20c8649403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00259-017-3621-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00259-017-3621-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids></links><search><creatorcontrib>Hillmer, Ansel T.</creatorcontrib><creatorcontrib>Li, Songye</creatorcontrib><creatorcontrib>Zheng, Ming-Qiang</creatorcontrib><creatorcontrib>Scheunemann, Matthias</creatorcontrib><creatorcontrib>Lin, Shu-fei</creatorcontrib><creatorcontrib>Nabulsi, Nabeel</creatorcontrib><creatorcontrib>Holden, Daniel</creatorcontrib><creatorcontrib>Pracitto, Richard</creatorcontrib><creatorcontrib>Labaree, David</creatorcontrib><creatorcontrib>Ropchan, Jim</creatorcontrib><creatorcontrib>Teodoro, Rodrigo</creatorcontrib><creatorcontrib>Deuther-Conrad, Winnie</creatorcontrib><creatorcontrib>Esterlis, Irina</creatorcontrib><creatorcontrib>Cosgrove, Kelly P.</creatorcontrib><creatorcontrib>Brust, Peter</creatorcontrib><creatorcontrib>Carson, Richard E.</creatorcontrib><creatorcontrib>Huang, Yiyun</creatorcontrib><title>PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans</title><title>European journal of nuclear medicine and molecular imaging</title><addtitle>Eur J Nucl Med Mol Imaging</addtitle><description>Purpose The α 7 nicotinic acetylcholine receptor (nAChR) is implicated in many neuropsychiatric disorders, making it an important target for positron emission tomography (PET) imaging. The first aim of this work was to compare two α 7 nAChRs PET radioligands, [ 18 F]ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-([ 18 F]fluorodibenzo[ b,d ]thiophene 5,5-dioxide) and [ 18 F]DBT-10 (7-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-2-([ 18 F]fluorodibenzo[ b,d ]thiophene 5,5-dioxide), in nonhuman primates. The second aim was to assess further the quantification and test-retest variability of [ 18 F]ASEM in humans. Methods PET scans with high specific activity [ 18 F]ASEM or [ 18 F]DBT-10 were acquired in three rhesus monkeys (one male, two female), and the kinetic properties of these radiotracers were compared. Additional [ 18 F]ASEM PET scans with blocking doses of nicotine, varenicline, and cold ASEM were acquired separately in two animals. Next, six human subjects (five male, one female) were imaged with [ 18 F]ASEM PET for 180 min, and arterial sampling was used to measure the parent input function. Different modeling approaches were compared to identify the optimal analysis method and scan duration for quantification of [ 18 F]ASEM distribution volume ( V T ). In addition, retest scans were acquired in four subjects (three male, one female), and the test-retest variability of V T was assessed. Results In the rhesus monkey brain [ 18 F]ASEM and [ 18 F]DBT-10 exhibited highly similar kinetic profiles. Dose-dependent blockade of [ 18 F]ASEM binding was observed, while administration of either nicotine or varenicline did not change [ 18 F]ASEM V T . [ 18 F]ASEM was selected for further validation because it has been used in humans. Accurate quantification of [ 18 F]ASEM V T in humans was achieved using multilinear analysis with at least 90 min of data acquisition, resulting in V T values ranging from 19.6 ± 2.5 mL/cm 3 in cerebellum to 25.9 ± 2.9 mL/cm 3 in thalamus. Test-retest variability of V T was 11.7 ± 9.8%. Conclusions These results confirm [ 18 F]ASEM as a suitable radiotracer for the imaging and quantification of α 7 nAChRs in humans.</description><subject>Cardiology</subject><subject>Imaging</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Nuclear Medicine</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Orthopedics</subject><subject>Radiology</subject><issn>1619-7070</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc1KxDAUhYsoOI4-gLssXVjNbdo0defP-AOKguNKJITMzUylk4xJK8wrufNFfCYzUxHcCOEmF853wuEkyT7QI6C0PA6UZkWVUihTxjNIxUYyAA5VWlJRbf6-S7qd7ITwSimITFSD5ONhNCb1XE1rOyXOkK_Pkthau7aOkyiN7bLRM9fUFolHjYvW-XBCFNFuvlBetfU7ktB2k-WKfgZx-XL6OLojyk767eJsnAIltSXW2Vk3V5YsfPywxXC4VpnOtzP0BN9V00U_Z_86RXKNhd1ky6gm4N7PPUyeLkfj8-v09v7q5vz0NtUsL0TKtRBKlXlRCshBMUZjUMNFaRivGLAYHAyajBnNdcFxkiGqic6oFjyvcsqGyUHvu_DurcPQynkdNDaNsui6IEHweATQIkqhl2rvQvBo5DqbX0qgctWL7HuRsRe56kWKyGQ9E6LWTtHLV9d5GxP9A30DxRmP3g</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Hillmer, Ansel T.</creator><creator>Li, Songye</creator><creator>Zheng, Ming-Qiang</creator><creator>Scheunemann, Matthias</creator><creator>Lin, Shu-fei</creator><creator>Nabulsi, Nabeel</creator><creator>Holden, Daniel</creator><creator>Pracitto, Richard</creator><creator>Labaree, David</creator><creator>Ropchan, Jim</creator><creator>Teodoro, Rodrigo</creator><creator>Deuther-Conrad, Winnie</creator><creator>Esterlis, Irina</creator><creator>Cosgrove, Kelly P.</creator><creator>Brust, Peter</creator><creator>Carson, Richard E.</creator><creator>Huang, Yiyun</creator><general>Springer Berlin Heidelberg</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans</title><author>Hillmer, Ansel T. ; Li, Songye ; Zheng, Ming-Qiang ; Scheunemann, Matthias ; Lin, Shu-fei ; Nabulsi, Nabeel ; Holden, Daniel ; Pracitto, Richard ; Labaree, David ; Ropchan, Jim ; Teodoro, Rodrigo ; Deuther-Conrad, Winnie ; Esterlis, Irina ; Cosgrove, Kelly P. ; Brust, Peter ; Carson, Richard E. ; Huang, Yiyun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3458-6c88aa74578141a330289f687f3693131821fef23fc6c56ed2eeadc20c8649403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cardiology</topic><topic>Imaging</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Nuclear Medicine</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Orthopedics</topic><topic>Radiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hillmer, Ansel T.</creatorcontrib><creatorcontrib>Li, Songye</creatorcontrib><creatorcontrib>Zheng, Ming-Qiang</creatorcontrib><creatorcontrib>Scheunemann, Matthias</creatorcontrib><creatorcontrib>Lin, Shu-fei</creatorcontrib><creatorcontrib>Nabulsi, Nabeel</creatorcontrib><creatorcontrib>Holden, Daniel</creatorcontrib><creatorcontrib>Pracitto, Richard</creatorcontrib><creatorcontrib>Labaree, David</creatorcontrib><creatorcontrib>Ropchan, Jim</creatorcontrib><creatorcontrib>Teodoro, Rodrigo</creatorcontrib><creatorcontrib>Deuther-Conrad, Winnie</creatorcontrib><creatorcontrib>Esterlis, Irina</creatorcontrib><creatorcontrib>Cosgrove, Kelly P.</creatorcontrib><creatorcontrib>Brust, Peter</creatorcontrib><creatorcontrib>Carson, Richard E.</creatorcontrib><creatorcontrib>Huang, Yiyun</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of nuclear medicine and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hillmer, Ansel T.</au><au>Li, Songye</au><au>Zheng, Ming-Qiang</au><au>Scheunemann, Matthias</au><au>Lin, Shu-fei</au><au>Nabulsi, Nabeel</au><au>Holden, Daniel</au><au>Pracitto, Richard</au><au>Labaree, David</au><au>Ropchan, Jim</au><au>Teodoro, Rodrigo</au><au>Deuther-Conrad, Winnie</au><au>Esterlis, Irina</au><au>Cosgrove, Kelly P.</au><au>Brust, Peter</au><au>Carson, Richard E.</au><au>Huang, Yiyun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans</atitle><jtitle>European journal of nuclear medicine and molecular imaging</jtitle><stitle>Eur J Nucl Med Mol Imaging</stitle><date>2017-06-01</date><risdate>2017</risdate><volume>44</volume><issue>6</issue><spage>1042</spage><epage>1050</epage><pages>1042-1050</pages><issn>1619-7070</issn><eissn>1619-7089</eissn><abstract>Purpose The α 7 nicotinic acetylcholine receptor (nAChR) is implicated in many neuropsychiatric disorders, making it an important target for positron emission tomography (PET) imaging. The first aim of this work was to compare two α 7 nAChRs PET radioligands, [ 18 F]ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-([ 18 F]fluorodibenzo[ b,d ]thiophene 5,5-dioxide) and [ 18 F]DBT-10 (7-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-2-([ 18 F]fluorodibenzo[ b,d ]thiophene 5,5-dioxide), in nonhuman primates. The second aim was to assess further the quantification and test-retest variability of [ 18 F]ASEM in humans. Methods PET scans with high specific activity [ 18 F]ASEM or [ 18 F]DBT-10 were acquired in three rhesus monkeys (one male, two female), and the kinetic properties of these radiotracers were compared. Additional [ 18 F]ASEM PET scans with blocking doses of nicotine, varenicline, and cold ASEM were acquired separately in two animals. Next, six human subjects (five male, one female) were imaged with [ 18 F]ASEM PET for 180 min, and arterial sampling was used to measure the parent input function. Different modeling approaches were compared to identify the optimal analysis method and scan duration for quantification of [ 18 F]ASEM distribution volume ( V T ). In addition, retest scans were acquired in four subjects (three male, one female), and the test-retest variability of V T was assessed. Results In the rhesus monkey brain [ 18 F]ASEM and [ 18 F]DBT-10 exhibited highly similar kinetic profiles. Dose-dependent blockade of [ 18 F]ASEM binding was observed, while administration of either nicotine or varenicline did not change [ 18 F]ASEM V T . [ 18 F]ASEM was selected for further validation because it has been used in humans. Accurate quantification of [ 18 F]ASEM V T in humans was achieved using multilinear analysis with at least 90 min of data acquisition, resulting in V T values ranging from 19.6 ± 2.5 mL/cm 3 in cerebellum to 25.9 ± 2.9 mL/cm 3 in thalamus. Test-retest variability of V T was 11.7 ± 9.8%. Conclusions These results confirm [ 18 F]ASEM as a suitable radiotracer for the imaging and quantification of α 7 nAChRs in humans.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s00259-017-3621-8</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1619-7070
ispartof European journal of nuclear medicine and molecular imaging, 2017-06, Vol.44 (6), p.1042-1050
issn 1619-7070
1619-7089
language eng
recordid cdi_proquest_miscellaneous_1861868105
source SpringerLink Journals - AutoHoldings
subjects Cardiology
Imaging
Medicine
Medicine & Public Health
Nuclear Medicine
Oncology
Original Article
Orthopedics
Radiology
title PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T05%3A15%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PET%20imaging%20of%20%CE%B17%20nicotinic%20acetylcholine%20receptors:%20a%20comparative%20study%20of%20%5B18F%5DASEM%20and%20%5B18F%5DDBT-10%20in%20nonhuman%20primates,%20and%20further%20evaluation%20of%20%5B18F%5DASEM%20in%20humans&rft.jtitle=European%20journal%20of%20nuclear%20medicine%20and%20molecular%20imaging&rft.au=Hillmer,%20Ansel%20T.&rft.date=2017-06-01&rft.volume=44&rft.issue=6&rft.spage=1042&rft.epage=1050&rft.pages=1042-1050&rft.issn=1619-7070&rft.eissn=1619-7089&rft_id=info:doi/10.1007/s00259-017-3621-8&rft_dat=%3Cproquest_cross%3E1861868105%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1861868105&rft_id=info:pmid/&rfr_iscdi=true